The Wharton Moneyball Post Game Podcast

Share

Wharton Moneyball: College Football Favorites, Human Endurance, & Soccer Analytics

Ep. 162

Show from 8/7/19


In this episode of Wharton Moneyball host Cade Massey flies solo. He kicks off the show talking about his favorite college football teams and his projections for the upcoming season. Next he brings on an expert in the limits of human endurance. How do you measure high intensity events and what is your endurance ceiling? Plus find out how we can grow soccer in the US and what analytics they're using to enhance in game experience.


Guests:

Herman Pontzer is an Associate Professor of Evolutionary Anthropology at Duke University. He is also an Associate Research Professor of Global Health at the Duke Global Health Institute. Through lab and field research, he investigates the physiology of humans and apes to understand how ecology, lifestyle, diet, and evolutionary history affect metabolism and health.

Follow him on Twitter @HermanPontzer


Bill Connelly is a College Football Writer for ESPN. He is also the Author of Study Hall and The 50 Best* College Football Teams of All Time.

Follow him on Twitter for all things College Football analytics at @ESPN_BillC


Chris Alexopoulos is the lead Soccer Producer for ESPN. Chris worked on every World Cup from 1994 to 2012.

Follow him on Twitter @ChrisZop

More Episodes

7/22/2020

7/22/2020: COVID-19, Sports, David Fajgenbaum

David Fajgenbaum, MD, MBA, MSc is a groundbreaking physician-scientist, disease hunter, and bestselling author of the acclaimed memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action. Fajgenbaum went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a possible treatment that has put him into an extended remission. Now, he is spreading this approach to advance cures for other diseases and sharing lessons he learned about living from nearly dying through Chasing My Cure.One of the youngest individuals ever appointed to the faculty at Penn Medicine and the top 1 percent youngest grant awardees of a leading NIH grant, Dr. Fajgenbaum is co-founder and executive director of the Castleman Disease Collaborative Network (CDCN) and Associate Director, Patient Impact, for the Penn Orphan Disease Center. He has been recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Before co-founding the CDCN, Dr. Fajgenbaum co-founded and led the Actively Moving Forward Support Network, a non-profit organization dedicated to supporting grieving college students. Dr. Fajgenbaum has been profiled in a cover story by The New York Times as well as by Good Morning America, CNN, and the Today Show, among others.Dr. Fajgenbaum earned a BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania Medical School, and MBA from The Wharton School. He is a former Division I college quarterback, state-champion weight lifter, and co-founder of a national grief support network.